Logo-1 (Camber Logo 1)
Pirfenidone Tablet, Film Coated
Product Images NDC 31722-873
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Pirfenidone (NDC 31722-873). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Camber-logo (Camber Logo)
Pirfenidonetabfigure1 (Pirfenidonetabfigure1)
A cumulative distribution plot showing the percentage of patients versus absolute change in %FVC from baseline to week 52. The chart compares Pirfenidone and placebo groups, illustrating patient proportions with worsening (decrease) or no decline (increase) in %FVC over time.*
Pirfenidonetabfigure2 (Pirfenidonetabfigure2)
A line graph comparing mean change in forced vital capacity (FVC) over 52 weeks between Pirfenidone and placebo groups. The x-axis represents time in weeks (0, 13, 26, 39, 52) and the y-axis shows mean change in FVC (mL). The graph shows two trend lines: one for Pirfenidone and one for placebo, indicating slower decline in FVC for Pirfenidone over time.*
Pirfenidonetabfigure3 (Pirfenidonetabfigure3)
A Kaplan-Meier survival curve depicting the percentage of patients alive over time in weeks, comparing Pirfenidone (n=278) to placebo (n=624). The graph includes hazard ratio (HR) with 95% confidence interval (CI) indicating survival comparison between Pirfenidone and placebo groups. A table below the graph shows the number of patients at risk at various time points for each group.*
267mg-carton-label (Pirferidone 267mg 90s Carton Label)
Pirfenidone Tablets 267 mg film-coated oral tablets packaging label by Camber Pharmaceuticals, Inc. The label shows a total count of 270 tablets (3 bottles of 90 each) and includes storage instructions, dosage information reference, and contact details. Manufactured by Annora Pharma Pvt. Ltd., India.*
267mg-cntr-label (Pirferidone 267mg Container Label)
Label for Pirfenidone Tablets 267 mg by Camber Pharmaceuticals, Inc. The label indicates oral film-coated tablets, containing 90 tablets per package. It features the NDC number 31722-872-90, storage instructions, a barcode, and manufacturer information including Annora Pharma Pvt. Ltd. in India.*
801mg-container-label (Pirferidone 801mg 90s Container Label)
Pirfenidone Tablets 801 mg film-coated tablets label by Camber Pharmaceuticals, Inc. The label shows a 90-tablet count and includes storage instructions (20° to 25°C), manufacturer and contact information, and a barcode. The label specifies the strength as 801 mg per tablet and indicates prescription use only.*
Structure (Structure)
Chemical structure of pirfenidone shown as a molecular diagram illustrating the arrangement of atoms in the compound.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
